$12.85
0.16% yesterday
Nasdaq, Apr 03, 10:00 pm CET
ISIN
US2681582019
Symbol
DVAX

Dynavax Technologies Corporation Stock price

$12.85
-0.68 5.03% 1M
+1.66 14.83% 6M
+0.08 0.63% YTD
+0.66 5.41% 1Y
+1.29 11.16% 3Y
+9.68 305.36% 5Y
-9.76 43.17% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.02 0.16%
ISIN
US2681582019
Symbol
DVAX
Sector
Industry

Key metrics

Market capitalization $1.59b
Enterprise Value $1.13b
P/E (TTM) P/E ratio 73.55
EV/FCF (TTM) EV/FCF 18.86
EV/Sales (TTM) EV/Sales 4.09
P/S ratio (TTM) P/S ratio 5.75
P/B ratio (TTM) P/B ratio 2.70
Revenue growth (TTM) Revenue growth 19.36%
Revenue (TTM) Revenue $277.25m
EBIT (operating result TTM) EBIT $-2.07m
Free Cash Flow (TTM) Free Cash Flow $60.16m
Cash position $713.83m
EPS (TTM) EPS $0.17
P/E forward 38.02
P/S forward 4.88
EV/Sales forward 3.48
Short interest 18.89%
Show more

Is Dynavax Technologies Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Dynavax Technologies Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Dynavax Technologies Corporation forecast:

4x Buy
80%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a Dynavax Technologies Corporation forecast:

Buy
80%
Sell
20%

Financial data from Dynavax Technologies Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
277 277
19% 19%
100%
- Direct Costs 49 49
1% 1%
18%
228 228
25% 25%
82%
- Selling and Administrative Expenses 160 160
4% 4%
58%
- Research and Development Expense 62 62
12% 12%
22%
5.98 5.98
122% 122%
2%
- Depreciation and Amortization 8.05 8.05
11% 11%
3%
EBIT (Operating Income) EBIT -2.07 -2.07
94% 94%
-1%
Net Profit 27 27
527% 527%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Dynavax Technologies Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dynavax Technologies Corporation Stock News

Neutral
PRNewsWire
about 7 hours ago
Dynavax's Board is Overseeing Record Operational and Financial Performance Outlines Extensive Engagement with Deep Track and Multiple Attempts to Reach a Resolution EMERYVILLE, Calif. , April 3, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today ...
Neutral
Business Wire
25 days ago
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dynavax”, “DVAX” or the “Company”), with ownership of approximately 14.34% of the Company's outstanding shares, today sent a letter to the Company's Board of Directors (the “Board”) related to Deep T...
Neutral
PRNewsWire
29 days ago
Opportunistic refinancing extends the maturity of most of existing debt with improved terms and reduces dilution to existing capital structure $225 million of convertible notes due in 2030 issued, including an exchange for the retirement of ~$185 million of existing convertible notes due in 2026 and ~$40 million of new money Dynavax repurchased ~$8 million of the Company's common stock in conne...
More Dynavax Technologies Corporation News

Company Profile

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

Head office United States
CEO Ryan Spencer
Employees 405
Founded 1996
Website www.dynavax.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today